Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Timing of Coronary stent thrombosis in patients treated with ticlopidine and aspirin
Autore:
Wilson, SH; Rihal, CS; Bell, MR; Velianou, JL; Holmes, DR; Berger, PB;
Indirizzi:
Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA Mayo Clin & Mayo Fdn Rochester MN USA 55905 Dis, Rochester, MN 55905 USA
Titolo Testata:
AMERICAN JOURNAL OF CARDIOLOGY
fascicolo: 7, volume: 83, anno: 1999,
pagine: 1006 - 1011
SICI:
0002-9149(19990401)83:7<1006:TOCSTI>2.0.ZU;2-8
Fonte:
ISI
Lingua:
ENG
Soggetto:
INTRAVASCULAR ULTRASOUND GUIDANCE; ANGIOPLASTY; PLACEMENT; ANTICOAGULATION; IMPLANTATION; MANAGEMENT; RESTENOSIS; OCCLUSION;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
24
Recensione:
Indirizzi per estratti:
Indirizzo: Berger, PB Mayo5Clin & Mayo Fdn, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 5590 Mayo Clin & Mayo Fdn 200 1st St SW Rochester MN USA 55905 5590
Citazione:
S.H. Wilson et al., "Timing of Coronary stent thrombosis in patients treated with ticlopidine and aspirin", AM J CARD, 83(7), 1999, pp. 1006-1011

Abstract

In patients receiving coronary stents treated with aspirin and coumadin, the peak incidence of stent thrombosis occurs on the fifth and sixth days following the implantation procedure. little is known about the timing of stent thrombosis in patients treated with aspirin and ticlopidine. We comparedthe timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin with the timing in those receiving coumadin and aspirin. A retrospective databank analysis was performed and 39 patients were identified who experienced stent thrombosis after successful coronary stent implantation. OF these, 21 held been treated with ticlopidine and aspirin and 18 with coumadin and aspirin therapy. The median time from stent implantation tostent thrombosis in the ticlopidine and aspirin group was 12 hours (interquartile range 6 to 72 hours) compared with 4 days in the coumadin and aspirin group (interquartile range 21 to 68 hours) (p <0.0001). There was no significant difference between the timing of stent thrombosis in patients treated with abciximab in addition to ticlopidine and aspirin (median 17 hours,interquartile range 6 to 29) versus ticlopidine and aspirin patients who did not receive abciximab (median 11 hours, interquartile range 9 to 12, p =0.57). Thus, in patients who receive coronary stents, stent thrombosis occurs much earlier after the procedure in patients treated with ticlopidine and aspirin than in patients treated with anticoagulation therapy. (C) 1999 by Excerpta Medico, Inc.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 14/07/20 alle ore 11:38:07